AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Feb 26, 2018
29821_dirs_2018-02-26_196017bb-0bd4-44f4-bcd0-73fbd7cba967.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-23
Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-23 | Common Stock | M | 3679.0000 | $0.0000 | Acquired | 99774.0000 | Direct |
| 2018-02-23 | Common Stock | F | 1678.0000 | $27.2000 | Disposed | 98096.0000 | Direct |
| 2018-02-24 | Common Stock | M | 2867.0000 | $0.0000 | Acquired | 100963.0000 | Direct |
| 2018-02-24 | Common Stock | F | 1308.0000 | $27.2000 | Disposed | 99655.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-23 | Deferred Stock Units | $ | M | 3679.0000 | Disposed | 2020-02-23 | Common Stock (3679.0000) | Direct |
| 2018-02-24 | Deferred Stock Units | $ | M | 2867.0000 | Disposed | 2019-02-24 | Common Stock (2867.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.